MICHAEL LANE: Open Payments
NPI 1669415188 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,034 in 32 payments from 11 companies in 2025. Trend: 2023 $1,302 · 2024 $3,088 · 2025 $1,034
Food & beverage: $835Education: $199
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $367 |
| Novartis Pharmaceuticals Corporation | 9 | $297 |
| ABBVIE INC. | 3 | $82 |
| Incyte Corporation | 3 | $71 |
| Organon LLC | 4 | $64 |
| UCB, Inc. | 3 | $62 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
| LEO Pharma Inc. | 1 | $21 |
| Galderma Laboratories, L.P. | 1 | $21 |
| GENZYME CORPORATION | 1 | $14 |
Products named: TREMFYA, Rhapsido, SKYRIZI, OPZELURA, VTAMA, Bimzelx, COSENTYX, Zoryve.
Industry payments across ID — which companies pay providers there.
